©The Author(s) 2016.
World J Hepatol. Nov 18, 2016; 8(32): 1392-1401
Published online Nov 18, 2016. doi: 10.4254/wjh.v8.i32.1392
Published online Nov 18, 2016. doi: 10.4254/wjh.v8.i32.1392
Table 3 The overall significant variables among the studied variables: Using independent-samples Kruskal-Wallis test
| Variables | P value |
| Age (yr) | 0.001 |
| HOMA-IR | 0.001 |
| ACE (U/mL) | 0.001 |
| Glucose (mmol) | 0.021 |
| ALT (U/L) | 0.001 |
| AST (U/L) | 0.001 |
| Platelet (× 109/L) | 0.001 |
| Insulin (uU/mL) | 0.001 |
| Creatinine (mg/dL) | 0.024 |
| Total Bilirubin (mg/dL) | 0.001 |
| Direct Bilirubin (mg/dL) | 0.002 |
| Albumin (mg/dL) | 0.001 |
| Portal vein diameter | 0.004 |
| Splenic diameter | 0.001 |
- Citation: Khattab M, Sakr MA, Fattah MA, Mousa Y, Soliman E, Breedy A, Fathi M, Gaber S, Altaweil A, Osman A, Hassouna A, Motawea I. Novel non-invasive biological predictive index for liver fibrosis in hepatitis C virus genotype 4 patients. World J Hepatol 2016; 8(32): 1392-1401
- URL: https://www.wjgnet.com/1948-5182/full/v8/i32/1392.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i32.1392